$AYTU
AYTU BIOPHARMA, INC

2023 Q2 Form 10-Q Financial Statement

#000155837023009367 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $30.73M $22.73M
YoY Change 11.96% -6.06%
Cost Of Revenue $12.17M $9.990M
YoY Change -3.46% -13.23%
Gross Profit $18.56M $12.74M
YoY Change 25.05% 0.45%
Gross Profit Margin 60.4% 56.06%
Selling, General & Admin $14.10M $19.98M
YoY Change -18.95% 15.11%
% of Gross Profit 75.97% 156.8%
Research & Development $470.0K $856.0K
YoY Change -87.29% -77.03%
% of Gross Profit 2.53% 6.72%
Depreciation & Amortization $2.120M $300.0K
YoY Change -5.61% -40.0%
% of Gross Profit 11.42% 2.35%
Operating Expenses $15.28M $21.30M
YoY Change -30.37% -68.37%
Operating Profit $3.280M -$8.558M
YoY Change -146.17% -84.34%
Interest Expense -$2.630M $1.358M
YoY Change 234.18% -2569.09%
% of Operating Profit -80.18%
Other Income/Expense, Net $1.358M
YoY Change -14.16%
Pretax Income -$2.460M -$7.200M
YoY Change -86.1% -86.43%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.460M -$7.200M
YoY Change -86.1% -86.43%
Net Earnings / Revenue -8.01% -31.67%
Basic Earnings Per Share -$1.93
Diluted Earnings Per Share -$0.60 -$1.93
COMMON SHARES
Basic Shares Outstanding 3.780M 3.573M
Diluted Shares Outstanding 3.727M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.00M $19.18M
YoY Change 18.8% -30.54%
Cash & Equivalents $22.99M $19.18M
Short-Term Investments
Other Short-Term Assets $868.0K $1.177M
YoY Change 37.12% 32.55%
Inventory $12.00M $13.64M
Prepaid Expenses $8.047M $10.43M
Receivables $28.90M $34.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $72.83M $78.47M
YoY Change 21.53% 0.66%
LONG-TERM ASSETS
Property, Plant & Equipment $3.900M $4.395M
YoY Change -38.06% -37.57%
Goodwill $0.00
YoY Change
Intangibles $58.97M $63.46M
YoY Change -16.51% -14.73%
Long-Term Investments
YoY Change
Other Assets $792.0K $892.0K
YoY Change 3.39% 15.25%
Total Long-Term Assets $63.63M $68.75M
YoY Change -18.1% -24.35%
TOTAL ASSETS
Total Short-Term Assets $72.83M $78.47M
Total Long-Term Assets $63.63M $68.75M
Total Assets $136.5M $147.2M
YoY Change -0.84% -12.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.50M $24.96M
YoY Change 122.99% 124.26%
Accrued Expenses $46.80M $49.59M
YoY Change 5.91% -7.27%
Deferred Revenue
YoY Change
Short-Term Debt $1.563M $10.40M
YoY Change -59.01% 207.33%
Long-Term Debt Due $100.0K $3.305M
YoY Change 4.17% 3205.0%
Total Short-Term Liabilities $69.02M $85.42M
YoY Change 7.1% 6.29%
LONG-TERM LIABILITIES
Long-Term Debt $14.70M $11.39M
YoY Change 2.95% -19.63%
Other Long-Term Liabilities $6.975M $7.920M
YoY Change -45.55% 42.01%
Total Long-Term Liabilities $6.975M $7.920M
YoY Change -45.55% 42.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $69.02M $85.42M
Total Long-Term Liabilities $6.975M $7.920M
Total Liabilities $97.11M $106.3M
YoY Change 6.09% -1.28%
SHAREHOLDERS EQUITY
Retained Earnings -$304.1M -$301.7M
YoY Change 5.41% 11.41%
Common Stock $343.5M $342.6M
YoY Change 2.67% 3.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $39.36M $40.91M
YoY Change
Total Liabilities & Shareholders Equity $136.5M $147.2M
YoY Change -0.84% -12.8%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$2.460M -$7.200M
YoY Change -86.1% -86.43%
Depreciation, Depletion And Amortization $2.120M $300.0K
YoY Change -5.61% -40.0%
Cash From Operating Activities $9.360M -$2.906M
YoY Change -231.92% -68.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$160.0K $1.000K
YoY Change 290.24% -101.43%
Cash From Investing Activities -$160.0K $1.000K
YoY Change 290.24% -101.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.410M 2.583M
YoY Change 384.33% 69.82%
NET CHANGE
Cash From Operating Activities 9.360M -2.906M
Cash From Investing Activities -160.0K 1.000K
Cash From Financing Activities -5.410M 2.583M
Net Change In Cash 3.790M -322.0K
YoY Change -145.92% -95.8%
FREE CASH FLOW
Cash From Operating Activities $9.360M -$2.906M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3025000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2367000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3271000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
766000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76667000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69221000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
9990000
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2023Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q2 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
63464000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
130000
CY2023Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
70632000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
892000
CY2022Q2 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2023Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
633000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
78465000
CY2023Q1 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#DerivativeLiabilitiesNoncurrent
CY2022Q2 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#DerivativeLiabilitiesNoncurrent
dei Entity Central Index Key
EntityCentralIndexKey
0001385818
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2022Q3 us-gaap Derivative Liability Valuation Technique Extensible List
DerivativeLiabilityValuationTechniqueExtensibleList
http://fasb.org/us-gaap/2022#ValuationTechniqueOptionPricingModelMember
CY2023Q1 us-gaap Derivative Liability Valuation Technique Extensible List
DerivativeLiabilityValuationTechniqueExtensibleList
http://fasb.org/us-gaap/2022#ValuationTechniqueOptionPricingModelMember
CY2022Q3 us-gaap Derivative Liability Valuation Technique Extensible List
DerivativeLiabilityValuationTechniqueExtensibleList
http://fasb.org/us-gaap/2022#ValuationTechniqueOptionPricingModelMember
CY2023Q1 us-gaap Derivative Liability Valuation Technique Extensible List
DerivativeLiabilityValuationTechniqueExtensibleList
http://fasb.org/us-gaap/2022#ValuationTechniqueOptionPricingModelMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38247
dei Entity Registrant Name
EntityRegistrantName
AYTU BIOPHARMA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0883144
dei Entity Address Address Line1
EntityAddressAddressLine1
373 Inverness Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 206
dei Entity Address City Or Town
EntityAddressCityOrTown
Englewood
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
437-6580
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
dei Trading Symbol
TradingSymbol
AYTU
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3780179
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19179000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19360000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34043000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21712000
CY2023Q1 us-gaap Inventory Net
InventoryNet
13637000
CY2022Q2 us-gaap Inventory Net
InventoryNet
10849000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10429000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7375000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1177000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
59929000
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2028000
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
68751000
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
77694000
CY2023Q1 us-gaap Assets
Assets
147216000
CY2022Q2 us-gaap Assets
Assets
137623000
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
14673000
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
10987000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49585000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44187000
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
10403000
CY2022Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
3813000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3305000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
96000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7450000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5359000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
85416000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
64442000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
11386000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14279000
CY2023Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1582000
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1796000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7920000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12798000
CY2023Q1 us-gaap Liabilities
Liabilities
106304000
CY2022Q2 us-gaap Liabilities
Liabilities
93315000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3779513
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3779513
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1928941
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1928941
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
342584000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
331386000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-301672000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-287078000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
40912000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
44308000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147216000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
137623000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22733000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24199000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
11513000
us-gaap Cost Of Revenue
CostOfRevenue
28599000
us-gaap Cost Of Revenue
CostOfRevenue
31780000
CY2023Q1 us-gaap Gross Profit
GrossProfit
12743000
CY2022Q1 us-gaap Gross Profit
GrossProfit
12686000
us-gaap Gross Profit
GrossProfit
48068000
us-gaap Gross Profit
GrossProfit
37441000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
856000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3282000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3630000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9409000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12804000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9743000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
33466000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28700000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7177000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7616000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22517000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23785000
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
45196000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2600000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
64649000
CY2023Q1 aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
734000
CY2022Q1 aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
1234000
aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
504000
aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
682000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1198000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1504000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3593000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4546000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
21301000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
66107000
us-gaap Operating Expenses
OperatingExpenses
65302000
us-gaap Operating Expenses
OperatingExpenses
130407000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8558000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-53421000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17234000
us-gaap Operating Income Loss
OperatingIncomeLoss
-92966000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1215000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-32000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3527000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
169000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
169000
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2573000
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-7000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
6167000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-7000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1358000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1045000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2640000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
166000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7200000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53291000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14594000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-92800000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-110000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7200000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-53291000
us-gaap Net Income Loss
NetIncomeLoss
-14594000
us-gaap Net Income Loss
NetIncomeLoss
-92690000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3726779
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3726779
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1484492
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1484492
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3099130
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3099130
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1360585
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1360585
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.93
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.93
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-35.90
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-35.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-68.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-68.13
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44308000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1177000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3564000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-701000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48348000
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3067000
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1095000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-6693000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
45817000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
902000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1393000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7200000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40912000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
137568000
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1519000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
270000
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-27851000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
111500000
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1229000
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4355000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
782000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-11548000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
105536000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1270000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3856000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
379000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-53291000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57748000
us-gaap Profit Loss
ProfitLoss
-14594000
us-gaap Profit Loss
ProfitLoss
-92690000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6699000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7926000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2600000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
64649000
us-gaap Share Based Compensation
ShareBasedCompensation
5146000
us-gaap Share Based Compensation
ShareBasedCompensation
4018000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
6167000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-7000
aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
504000
aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
682000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
413000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-268000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
42000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
44000
aytu Write Off Of Deferred Debt Issuance Cost Net
WriteOffOfDeferredDebtIssuanceCostNet
-193000
us-gaap Inventory Write Down
InventoryWriteDown
199000
us-gaap Inventory Write Down
InventoryWriteDown
352000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
13000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-152000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12335000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-647000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2987000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-91000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3603000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1406000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3720000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8099000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7031000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1252000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
83000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-52000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14494000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21728000
us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
3138000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-38000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
69000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
38000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3207000
aytu Proceeds From Issuance Of Common Stock And Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
13012000
aytu Proceeds From Issuance Of Common Stock And Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
12700000
aytu Payments For Fixed Payment Arrangement
PaymentsForFixedPaymentArrangement
4117000
aytu Payments For Fixed Payment Arrangement
PaymentsForFixedPaymentArrangement
3277000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
6590000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-4549000
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
73000
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
16075000
us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
15000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
92000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
363000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14275000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2647000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-181000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22288000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19360000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49901000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19179000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27613000
us-gaap Interest Paid Net
InterestPaidNet
2861000
us-gaap Interest Paid Net
InterestPaidNet
3080000
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
473000
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19200000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34000000.0
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7200000
us-gaap Net Income Loss
NetIncomeLoss
-14600000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-301700000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14500000
us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Prior Period Reclassification</span>. Certain prior year amounts in the condensed consolidated statements of operations and statements of cash flows have been reclassified to conform to the current year presentation, including a reclassification made in the presentation of amortization of intellectual property, and a reclassification of fair value adjustment from contingent consideration. Amortization of intellectual property was previously included in research and development expenses and is currently recorded in amortization of intangible assets expenses on the condensed consolidated statements of operations. Gain or loss from the fair value of contingent consideration was previously included in Other expense, net, and is currently recorded in operating expenses on the condensed consolidated statements of operations. These reclassifications did not impact operating results or cash flows for the nine months ended March 31, 2023 and 2022 or its financial position as of March 31, 2023 or June 30, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Management uses estimates and assumptions relating to reporting amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying condensed consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, revenue recognition, allowance for doubtful accounts, determination of variable consideration for accruals of chargebacks, administrative fees and rebates, government rebates, returns and other allowances, write-downs for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, the value of goodwill, income tax provision, deferred taxes and valuation allowance, determination of right-of-use assets and lease liabilities, purchase price allocations, the depreciable lives of long-lived assets, classification of warrants equity versus liability, and the valuation of derivative warrant liability. Because of the uncertainties inherent in such estimates, actual results may differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for reasonableness.</p>
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-7000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
130000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53291000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-53291000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-35.90
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-35.90
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3856000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-53291000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-7000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
166000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-92800000
us-gaap Net Income Loss
NetIncomeLoss
-92690000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-68.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-68.13
us-gaap Profit Loss
ProfitLoss
-92690000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-7000
us-gaap Net Income Loss
NetIncomeLoss
-92690000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
328737000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270989000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57748000
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1796000
CY2022Q2 us-gaap Liabilities
Liabilities
93315000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
331386000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-287078000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44308000
aytu Inventory Write Down And Impairment
InventoryWriteDownAndImpairment
200000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22733000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24199000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76667000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69221000
CY2023Q1 aytu Inventory Write Down And Impairment
InventoryWriteDownAndImpairment
100000
CY2022Q1 aytu Inventory Write Down And Impairment
InventoryWriteDownAndImpairment
2000000.0
aytu Inventory Write Down And Impairment
InventoryWriteDownAndImpairment
2400000
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2223000
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1814000
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2817000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1838000
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8597000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7197000
CY2023Q1 us-gaap Inventory Net
InventoryNet
13637000
CY2022Q2 us-gaap Inventory Net
InventoryNet
10849000
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
5412000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
5446000
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3384000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
2421000
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2028000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3025000
CY2023Q1 us-gaap Depreciation
Depreciation
300000
CY2022Q1 us-gaap Depreciation
Depreciation
500000
us-gaap Depreciation
Depreciation
1000000.0
us-gaap Depreciation
Depreciation
1300000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
360000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
316000
us-gaap Operating Lease Cost
OperatingLeaseCost
1076000
us-gaap Operating Lease Cost
OperatingLeaseCost
942000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
27000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
65000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
71000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
130000
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
14000
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
18000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
51000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
55000
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
CY2022Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
3000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
7000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
11000
CY2023Q1 us-gaap Lease Cost
LeaseCost
403000
CY2022Q1 us-gaap Lease Cost
LeaseCost
402000
us-gaap Lease Cost
LeaseCost
1205000
us-gaap Lease Cost
LeaseCost
1138000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2367000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3271000
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
174000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
256000
CY2023Q1 aytu Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
2541000
CY2022Q2 aytu Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
3527000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1252000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1227000
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
91000
CY2022Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
96000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1154000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2090000
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
15000
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
84000
CY2023Q1 aytu Operating Lease And Finance Lease Liability
OperatingLeaseAndFinanceLeaseLiability
2512000
CY2022Q2 aytu Operating Lease And Finance Lease Liability
OperatingLeaseAndFinanceLeaseLiability
3497000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y11M8D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M17D
CY2023Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y1M13D
CY2022Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M23D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0768
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
2600000
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0748
CY2023Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0654
CY2022Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0643
us-gaap Operating Lease Payments
OperatingLeasePayments
1076000
us-gaap Operating Lease Payments
OperatingLeasePayments
942000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
7000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
12000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
73000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
76000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
360000
CY2023Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
23000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1379000
CY2023Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
87000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
749000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
90000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
46000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2624000
CY2023Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
110000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
218000
CY2023Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
4000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2406000
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
106000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
86954000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18094000
CY2023Q1 aytu Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
5396000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
63464000
CY2023Q1 aytu Indefinite Lived Intangible Assets Excluding Goodwill Before Accumulated Impairment
IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeAccumulatedImpairment
2600000
CY2023Q1 aytu Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment
2600000
CY2023Q1 aytu Indefinite Lived Intangible Assets Excluding Goodwill Before Accumulated Impairment
IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeAccumulatedImpairment
2600000
CY2023Q1 aytu Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment
2600000
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
89554000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18094000
CY2023Q1 aytu Intangible Assets Net Excluding Goodwill Accumulated Impairment
IntangibleAssetsNetExcludingGoodwillAccumulatedImpairment
7996000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
63464000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
91620000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16530000
CY2022Q2 aytu Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
7058000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
68032000
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94220000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16530000
CY2022Q2 aytu Intangible Assets Net Excluding Goodwill Accumulated Impairment
IntangibleAssetsNetExcludingGoodwillAccumulatedImpairment
7058000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
70632000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1518000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6074000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5934000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5683000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5653000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
5553000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
33049000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
63464000
CY2023Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1500000
CY2022Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
2000000.0
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
4600000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
6100000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 aytu Accrued Saving Offers
AccruedSavingOffers
18370000
CY2022Q2 aytu Accrued Saving Offers
AccruedSavingOffers
12711000
CY2023Q1 aytu Accrued Program Related Liabilities
AccruedProgramRelatedLiabilities
10287000
CY2022Q2 aytu Accrued Program Related Liabilities
AccruedProgramRelatedLiabilities
9468000
CY2023Q1 aytu Accrued Customer And Product Related Fees Current
AccruedCustomerAndProductRelatedFeesCurrent
6379000
CY2022Q2 aytu Accrued Customer And Product Related Fees Current
AccruedCustomerAndProductRelatedFeesCurrent
7817000
CY2023Q1 aytu Return Reserve
ReturnReserve
4708000
CY2022Q2 aytu Return Reserve
ReturnReserve
5770000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6864000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4765000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2977000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3656000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49585000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44187000
CY2023Q1 aytu Fixed Payment Arrangements
FixedPaymentArrangements
10678000
CY2022Q2 aytu Fixed Payment Arrangements
FixedPaymentArrangements
13051000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2406000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3317000
CY2023Q1 aytu Contingent Value Rights Liabilities Fair Value Disclosure
ContingentValueRightsLiabilitiesFairValueDisclosure
465000
CY2022Q2 aytu Contingent Value Rights Liabilities Fair Value Disclosure
ContingentValueRightsLiabilitiesFairValueDisclosure
578000
CY2022Q2 aytu Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Liability
BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationLiability
396000
CY2023Q1 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
1821000
CY2022Q2 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
815000
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
15370000
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
18157000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7450000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5359000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7920000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12798000
CY2020Q1 aytu Contingent Value Rights Business Combination Contingent Consideration Milestone Payable Amount Maximum
ContingentValueRightsBusinessCombinationContingentConsiderationMilestonePayableAmountMaximum
16000000.0
CY2020Q1 aytu Contingent Value Rights Business Combination Contingent Consideration Milestone Payable Shares Maximum
ContingentValueRightsBusinessCombinationContingentConsiderationMilestonePayableSharesMaximum
470000
CY2023Q1 aytu Contingent Value Rights Business Combination Contingent Consideration Milestone Payable Amount Maximum
ContingentValueRightsBusinessCombinationContingentConsiderationMilestonePayableAmountMaximum
5000000.0
CY2023Q1 aytu Contingent Value Rights Liabilities Fair Value Disclosure
ContingentValueRightsLiabilitiesFairValueDisclosure
500000
CY2022Q2 aytu Contingent Value Rights Liabilities Fair Value Disclosure
ContingentValueRightsLiabilitiesFairValueDisclosure
600000
CY2022Q1 aytu Debt Instrument Interest Payment Term
DebtInstrumentInterestPaymentTerm
P18M
CY2022Q1 aytu Debt Instrument Interest Payment Extension Term
DebtInstrumentInterestPaymentExtensionTerm
P6M
CY2022Q1 aytu Interest Only Period Further Extension Term
InterestOnlyPeriodFurtherExtensionTerm
P12M
CY2022Q1 aytu Debt Instrument Term Of Trailing Months Revenue
DebtInstrumentTermOfTrailingMonthsRevenue
P12M
CY2022Q1 aytu Debt Instrument Prepayment Fee Percentage
DebtInstrumentPrepaymentFeePercentage
0.030
CY2022Q1 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
600000
CY2022Q1 us-gaap Share Price
SharePrice
25.00
us-gaap Loan Processing Fee
LoanProcessingFee
400000
CY2023Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.1537
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
700000
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
400000
us-gaap Interest Expense Debt
InterestExpenseDebt
2000000.0
us-gaap Interest Expense Debt
InterestExpenseDebt
400000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
15000000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
15000000
CY2023Q1 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
638000
CY2022Q2 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
638000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1053000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1443000
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
106000
CY2022Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
180000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
14691000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
14375000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3305000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
96000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
11386000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14279000
CY2023Q1 aytu Long Term Debt And Finance Lease Liability Maturity Year One
LongTermDebtAndFinanceLeaseLiabilityMaturityYearOne
91000
CY2023Q1 aytu Long Term Debt And Finance Lease Liability Maturity Year Two
LongTermDebtAndFinanceLeaseLiabilityMaturityYearTwo
3230000
CY2023Q1 aytu Long Term Debt And Finance Lease Liability Maturity Year Three
LongTermDebtAndFinanceLeaseLiabilityMaturityYearThree
12423000
CY2023Q1 aytu Long Term Debt And Finance Lease Liability Gross
LongTermDebtAndFinanceLeaseLiabilityGross
15744000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1053000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3305000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
11386000
CY2022Q2 aytu Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilityValue
13051000
aytu Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilityGainLossIncludedInEarnings
-1202000
aytu Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilitySettlements
3575000
CY2023Q1 aytu Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilityValue
10678000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3899
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
209.70
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M7D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
49212
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
152
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
126.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
175
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
131.45
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
52784
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.42
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3M21D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2920
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
227.28
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y5M8D
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
200000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
902000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1270000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5146000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4018000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1788829
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
553170
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22733000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24199000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76667000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69221000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7200000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-53291000
us-gaap Net Income Loss
NetIncomeLoss
-14594000
us-gaap Net Income Loss
NetIncomeLoss
-92690000
CY2023Q1 us-gaap Assets
Assets
147216000
CY2022Q2 us-gaap Assets
Assets
137623000

Files In Submission

Name View Source Status
aytu-20230331_cal.xml Edgar Link unprocessable
0001558370-23-009367-index-headers.html Edgar Link pending
0001558370-23-009367-index.html Edgar Link pending
0001558370-23-009367.txt Edgar Link pending
0001558370-23-009367-xbrl.zip Edgar Link pending
aytu-20230331.xsd Edgar Link pending
aytu-20230331x10q.htm Edgar Link pending
aytu-20230331x10q001.jpg Edgar Link pending
aytu-20230331xex10d1.htm Edgar Link pending
aytu-20230331xex10d2.htm Edgar Link pending
aytu-20230331xex10d3.htm Edgar Link pending
aytu-20230331xex10d3001.jpg Edgar Link pending
aytu-20230331xex31d1.htm Edgar Link pending
aytu-20230331xex31d2.htm Edgar Link pending
aytu-20230331xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
aytu-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aytu-20230331_lab.xml Edgar Link unprocessable
aytu-20230331_pre.xml Edgar Link unprocessable
aytu-20230331x10q_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending